Healthcare: How’s It Going to Be for AbbVie, Regeneron, Clovis, and More

<p>AbbVie is developing new drugs to sidestep expiring patents on its best-seller, and a new FDA approval could be on deck at Clovis Oncology. Also, how Novartis plans to shake-up a multibillion dollar indication.</p>